B. Demers

Statistics

Publications

Citations

197

H-Index

Active since

1998

Affiliations

University of Ulsan(Current)

B. Demers is an author at University of Ulsan specializing in antibody-drug conjugates, antibody-drug conjugate antibodies, and monoclonal antibodies in oncology.

Publications per year

1998–2022

Publications

Induction of type III secretion in Shigella flexneri is associated with differential control of transcription of genes encoding secreted proteins

B. Demers · The EMBO Journal · 1998 · 106 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody–drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study

Anas Gazzah, Philippe L. Bédard, Cinta Hierro et al. · Annals of Oncology · 2022 · 81 citations

Pharmacy, Oncology, Pharmacology +17

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)

A. Gazzah, Neda Stjepanovic, Min‐Hee Ryu et al. · European Journal of Cancer · 2016 · 10 citations

Pharmacy, Oncology, Pharmacology +13

1–3 of 3